Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Assay Services In Asia Middle East
26 services found
by:Science in Action based inNess Ziona, ISRAEL
In vitro migration and invasion assays provide a simple and fast quantitative platform to measure cellular migratory or invasive phenotypes, in vitro. In this assay, cells are allowed to migrate through an artificial membrane towards a chemo-attractant gradient. The efficiency of this process is assessed by fluorometric analysis. ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
HemeMARK™ is a next-generation sequencing assay that analyzes 45 cancer-related gene mutations in hematological malignancies including myeloid and lymphoid ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D co-culture platform developed and optimized to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific microenvironment ...
Manufactured by:Instant NanoBiosensors Co., Ltd. (INB) based inTaipei City, TAIWAN
High-throughput screening is a crucial part of drug discovery by allowing researchers to find leads from thousands of different candidates in a timely manner. Instant NanoBiosensors offers high-throughput ELISA services utilizing the most cost-effective multiplex assays and a wide range of single plex kits. Charge your scientific research and preclinical data collection by ...
Manufactured by:Quark Biosciences, Inc. based inZhubei, TAIWAN
Choose NextAmp™ Analysis System to optimize biomarker selection and to accelerate the clinical research towards next precision medicine ...
Manufactured by:Instant NanoBiosensors Co., Ltd. (INB) based inTaipei City, TAIWAN
The brand-new FOPPR Biomarker Analysis Service uses our unique & patented FOPPR™ Technology for real-time antibody-antigen interaction analysis, and can provide kinetic curves of antibody-antigen pairs as well as affinity analysis by data processing. This method does not require extra antibody adsorption-desorption assays thus reducing the complication of experiment ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology’s Analytical Testing platforms can be used to gather additional data at the endpoint of a preclinical model or ex vivo assay. Using multiplex cytokine assays with flow cytometry readouts, immune cell cytokine intracellular and extracellular staining upon activation can be assessed. Champions Oncology can also collect ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Gencurix R&D Center is performing ceaseless research activities to developing the ‘multiplex assay’ which is core technology for economy in expenditures, time and samples. We have accumulated research capabilities and experiences of entire development process of molecular diagnostic ...
Manufactured by:Mimetas B.V. based inLeiden, NETHERLANDS
To this end, MIMETAS aims to capture the essence of diseases in fit-for-purpose in vitro models. We are fully committed to reducing human disease complexity into functional and screenable ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay developed and optimized to interrogate the responses of your immuno-oncology drugs in only 4 days using primary patient specimens. ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers such as steroidal and hormonal substances in the low picogram range. ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
Pharma and biotech companies of all sizes have chosen us as the preferred bioanalytical partner. SGS has the expertise to both develop assays de novo (including immunoassays) and to support large scale routine sample analyses, from pre-clinical to clinical ...
Manufactured by:Minaris Regenerative Medicine, LLC based inAllendale, NEW JERSEY (USA)
To ensure we provide the best possible service to you, Minaris Regenerative Medicine and our cell & gene therapy specialists offer guidance at every stage of your process. ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
The AlphaLiquid® platform enables enhanced safety, speed and efficiency in clinical trials for drug ...
by:SciGenom Labs Pvt. Ltd. based inCochin, INDIA
SciGenom offers production of high-affinity monoclonal reagent-grade Fabs and full-length IgGs for use in basic and clinical research labs. It uses licensed proprietary phage display libraries to generate synthetic Fabs/IgGs. The diversity of peptides displayed in the library is >10^10, which guarantees high affinity Fabs against antigens from any ...
by:Strand Life Sciences Pvt. Ltd. based inBangalore, INDIA
Strand has extensive experience in validating NGS-based panels under CAP- and CLIA-settings: be it germline panels, somatic tumor panels, or liquid biopsy panels, and be it small panels with tens of genes, to large panels with thousands of ...
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
Antibody development process harnessing our HuPhage library encompass biopanning for screening scFv hits targeting specific antigens, IgG conversion of best scFv candidates, and further in-house antibody production and ...
by:Eurofins Scientific based inKraainem, BELGIUM
Complete preclinical service: Early and full drug development is regulatory-driven and complex. The priority in this selection process is to achieve the safety and efficacy of a new molecular entity. The preclinical activity includes mainly safety and pharmacological testing accompanied by metabolism, bioanalysis, biomarker development and pharmaceutical analysis. Eurofins offers the whole panel ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
Leveraging our own image analysis and image management solutions, HALO, HALO AI and HALO Link, as well as the expertise of our PHARMA SERVICES and algorithm development teams, we offer a wide range of analysis services to pharmaceutical, contract research organizations and research institutes around the world. Whether you require an end-to-end solution or à la carte analysis services, we ...